Tian'an Pharmaceutical Co., Ltd. (TNPH)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 142.84 Thousand | 7500.00 | - | - | - | - |
| Cost of Revenue | 75.25 Thousand | - | - | - | - | - |
| Gross Profit | 67.58 Thousand | 7500.00 | - | - | - | - |
| Operating Expenses | 78.23 Thousand | 40.94 Thousand | 31.39 Thousand | 80.07 Thousand | 114.15 Thousand | 22.8 Thousand |
| Selling, General and Administrative Expenses | 78.23 Thousand | 40.94 Thousand | 31.39 Thousand | 80.07 Thousand | 114.15 Thousand | 22.8 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 153.49 Thousand | 40.94 Thousand | 31.39 Thousand | 80.07 Thousand | 114.15 Thousand | 22.8 Thousand |
| Operating Income | -10.65 Thousand | -33.45 Thousand | -31.39 Thousand | -80.07 Thousand | -114.15 Thousand | -22.8 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 630.00 | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | - |
| Earnings before Tax | -10.3 Thousand | -20.44 Thousand | -31.39 Thousand | -80.07 Thousand | -114.15 Thousand | -22.72 Thousand |
| Net Income | -16.02 Thousand | -20.44 Thousand | -31.39 Thousand | -80.07 Thousand | -114.15 Thousand | -22.72 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 348.11 Million | 65.86 Million | 49.99 Million | 49.99 Million | 49.99 Million | 49.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 348.11 Million | 65.86 Million | 49.99 Million | 49.99 Million | 49.99 Million | 49.99 Million |
| Gross Margin | 0.47 | 1.00 | - | - | - | - |
| EBIT Margin | -0.07 | -4.46 | - | - | - | - |
| Profit Margin | -0.11 | -2.73 | - | - | - | - |
| EBITDA | -10.15 Thousand | -20.44 Thousand | -31.39 Thousand | -80.07 Thousand | -114.15 Thousand | -22.8 Thousand |
| Earnings Before Tax Margin | -0.07 | -4.46 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 142.84 Thousand | 110.47 Thousand | 31.2 Thousand | - |
| Cost of Revenue | - | - | 75.25 Thousand | 69.07 Thousand | 6174.00 | - |
| Gross Profit | - | - | 67.58 Thousand | 41.4 Thousand | 25.03 Thousand | - |
| Operating Expenses | 2985.00 | 6092.00 | 78.23 Thousand | -10.74 Thousand | 77.1 Thousand | 1664.00 |
| Selling, General and Administrative Expenses | 2985.00 | 6092.00 | - | -10.74 Thousand | 77.1 Thousand | 1664.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2985.00 | 6092.00 | 153.49 Thousand | 69.07 Thousand | 83.27 Thousand | 1664.00 |
| Operating Income | -2980.00 | -6090.00 | -10.65 Thousand | 41.4 Thousand | -52.07 Thousand | -1660.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -264.00 | 630.00 | 630.00 | -8142.00 | -122.08 Thousand |
| Earnings before Tax | -2985.00 | -6092.00 | -10.3 Thousand | 52.44 Thousand | -52.02 Thousand | -1664.00 |
| Net Income | -2985.00 | -5828.00 | -16.02 Thousand | 38.57 Thousand | -43.87 Thousand | -1664.00 |
| Earnings Per Share Basic | - | - | - | - | -0.00 | - |
| Earnings Per Share Diluted | - | - | - | - | -0.00 | - |
| Weighted Average Shares Outstanding | 800 Million | 800 Million | 348.11 Million | 800 Million | 421.12 Million | 81.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 800 Million | 800 Million | 348.11 Million | 800 Million | 421.12 Million | 81.72 Million |
| Gross Margin | - | - | 0.47 | 0.37 | 0.80 | - |
| EBIT Margin | - | - | - | 0.38 | -1.67 | - |
| Profit Margin | - | - | -0.11 | 0.35 | -1.41 | - |
| EBITDA | -2980.00 | -6090.00 | - | 41.55 Thousand | -52.07 Thousand | -1660.00 |
| Earnings Before Tax Margin | - | - | -0.07 | 0.37 | -1.67 | - |
0IRE
ENRG
GAYGF
PLIN
1558
CARM